Stephen Moore – What Lies Ahead: Policy Implications from the 2020 Election

December 3, 2020
San Francisco, CA, USA
150320221647327579

Webinar and Discussion with Economist Stephen Moore

 

Dec 3, 2020
11:00 AM Pacific Time
(US and Canada)

 

After registering, you will receive a confirmation email containing information about joining the webinar.

Join us for a webinar and discussion with economist Stephen Moore on the domestic policy implications from 2020 election. Now that voters have spoken, we will analyze the outcomes of major national and state races and explore what the results mean for jobs and the economy. Moore, a member of President Trump’s economic task force, will offer his insights into what lies ahead for our nation amid the ongoing pandemic, civil unrest, and increasing political divide.
This live webinar will feature a Q&A session with attendees hosted by PRI Senior Fellow Steven F. Hayward, Ph.D. Attendees are encouraged to submit questions using the “Q&A” feature on the Zoom platform.


 

WEBINAR SPEAKERS

 

Stephen Moore (Distinguished Visiting Fellow, Institute for Economic Freedom @Heritage Foundation)
who formerly wrote on the economy and public policy for The Wall Street Journal, is the Distinguished Visiting Fellow, Project for Economic Growth, at The Heritage Foundation.

 

Dr. Steven F. Hayward, Ph.D. (Senior Fellow @Pacific Research Institute)
writes frequently on a wide range of issues, including environmentalism, law, economics, and public policy, and has published dozens of articles in scholarly and popular journals. His work has appeared in National Review, New York Times, Wall Street Journal, Reason, The Weekly Standard, Policy Review, and Chicago Tribune.
Tell Your Friends

Related

Modern,Medical,Research,Laboratory,With,Microscope,And,Test,Tubes,With

Chaos At The FDA Benefits America’s Rivals—At The Expense Of America’s Patients

Chaos has become the norm at the U.S. Food and Drug Administration. And it’s putting American patients, not to mention our country’s world-leading life sciences ...
pharmaceutical warehouse.

Democrats Can’t End Private-Sector Drug Innovation Fast Enough

In November, a group of Democrats in the U.S. House made clear that they’ll sacrifice medical innovation for lower drug prices if they ever reclaim ...
Modern,Medical,Research,Laboratory,With,Microscope,And,Test,Tubes,With

The real story behind Trump’s GLP-1 price cut: Markets still rule

President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 weight-loss drugs dispensed through Medicare ...
Scroll to Top